Research Article
Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq
Table 7
Comparison of some parameters, treatment options, and disease-related complications between the current study and some other related studies.
| Parameter | Current study () % | Lebanon () 2000 [28] | Optimal care () 2010 [34] | Iran () 2011 [36] | Basra () 2013 [35] | Dohuk () 2014 [17] | Italy () 2014 [37] | Sri Lanka () 2019 [38] |
| Splenectomized | 32.7 | 59 | 55.7 | 46.9 | | 23.0 | 49 | 12.0 | Serum ferritin (μg/L) | <1000 | 76.7 | | 64.4 | | 55 | 67.6 | | | >1000 | 23.3 | | 35.6 | | 45 | 32.4 | | | Treatment | Transfusion | | | | | | | | | Never transfused | 20.8 | 28.8 | 23.8 | 27.5 | 21.2 | 32.4 | 53 | 4.0 | Occasionally | 47.2 | 58.9 | 24.5 | 45.5 | 78.8 | 51.4 | 34 | 42 | Regularly | 32.1 | 12.3 | 51.7 | 27 | | 16.2 | 13 | 44 | Iron chelation | 39.6 | | 47.5 | | | 14.9 | 56 | 46 | Hydroxyurea | 47.2 | | 34.6 | | | 2.7 | 16 | | Complications | Facial deformity | 62.3 | 44 | | | | 73 | | | Osteoporosis | 28.3 | | 22.9 | 53 | 30.0 | | 49 | | Growth retardation (height < 3rd percentile) | 27.8 | | | | 42.5 | 31.3 | | 26.7 | Subclinical hypothyroidism | 16.8 | | | | | | 33.3 | | Cholelithiasis | 13.8 | | 17.1 | 9.8 | 2.5 | | | 10.0 | PHT | 11.3 | | 11 | 23.5 | 5.0 | 20.4 | | 33.3 | Abnormal liver function | 7.5 | | 9.8 | 29.3 | | 13.5 | | |
|
|
Not mentioned in the study. |